Hem › Hidradenitis suppurativa › Texas
Kliniska studier för Hidradenitis suppurativa i Texas
8 studier för Hidradenitis suppurativa söker deltagare vid platser i Texas.
Städer i Texas
Officiell studietext (engelska)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Center for Clinical Studies-Lee, Webster
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Dallas
- Oruka Therapeutics Investigative Site, Missouri City
- Oruka Therapeutics Investigative Site, San Antonio
RekryterarFas 2
Ålder 18 till 79 · Alla kön · Uppdaterad 24 sep. 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Elligo Health Research/The Woodlands Dermatology Associates- Site Number : 8400020, The Woodlands
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US021, Bellaire
- Investigative Site US078, Dallas
- Investigative Site US010, Dallas
- och 3 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT06855498Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- UT Southwestern Medical Center, Department of Dermatology- Site Number : 8400022, Dallas
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT07170917Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Bellaire Dermatology Associates Bda, Bellaire
- Texas Dermatology Research Center, Dallas
- 3A Research Llc West Location, El Paso
RekryterarFas 2
Ålder 12 till 17 · Alla kön · Uppdaterad 6 aug. 2026 · NCT07213973A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- The University of Texas MD Anderson Cancer Center, Houston
RekryterarObservationsstudie
Ålder 18 till 71 · Alla kön · Uppdaterad 16 apr. 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Arlington Research Center, Inc., Arlington
- Texas Dermatology Research Center, Dallas
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 6 mars 2026 · NCT07244263Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.